Dhomen N, Reis-Filho JS, da Rocha Dias S, Hayward R, Savage K, Delmas V et al
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may have a welcome benefit in addition to weight loss and glycemic control, with new data presented at ObesityWeek, the annual meeting of the Obesity Society, showing that use of these medications is associated with a reduction in problematic alcohol use
For most adults on GLP-1 therapy for weight management, NICE guidelines recommend a moderate calorie deficit of approximately 600 calories below your total daily energy expenditure (TDEE)
However, the effects of GSH on fat grafts are unclear
This synthetic peptide, derived from the fragment 177-191 of human growth hormone (hGH), is designed to selectively stimulate fat metabolism without engaging growth hormone receptors that influence tissues beyond fat cells (2)